Nifedipina Mylan Generics (Nifedipine)

Nifedipine blocks L-type calcium channels on vascular smooth‑muscle cells and cardiac myocytes. By reducing calcium entry, it causes arterial vasodilation, lowers peripheral resistance, and decreases myocardial oxygen demand, which together lower blood pressure and relieve chest pain.

The appropriate dose is determined by the prescribing healthcare professional based on the individual’s condition, response, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for nifedipine in pregnancy and lactation are limited. It should only be used if the potential benefit outweighs the risk, and the decision must be made by a qualified healthcare provider after careful evaluation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nifedipine belongs to the dihydropyridine calcium‑channel blocker class, which primarily causes arterial vasodilation. Compared with beta‑blockers, it has less effect on heart rate, and unlike ACE inhibitors, it does not interfere with the renin‑angiotensin system. Choice depends on patient profile and comorbidities.

Store the product at room temperature, below 25 °C, in the original container. Protect it from moisture and direct sunlight. Do not use if the packaging is damaged or the tablets appear discolored.

The medication is taken orally. Swallow the tablet whole with a full glass of water, preferably at the same time each day. Do not crush, chew, or split extended‑release formulations unless instructed by a pharmacist.

Serious adverse events include severe hypotension, myocardial infarction, and allergic reactions such as rash, angioedema, or anaphylaxis. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, chest pain, or signs of an allergic response.

Individuals with known hypersensitivity to nifedipine or any component of the formulation, those experiencing severe hypotension, cardiogenic shock, or recent myocardial infarction should avoid this medication. A healthcare professional must evaluate any contraindications before prescribing.